ProQR Therapeutics (PRQR) EPS (Weighted Average and Diluted) Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,178.57% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 30.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.35% |
| Sep 30, 2025 | 6.58% |
| Jun 30, 2025 | -195.75% |
| Mar 31, 2025 | -22.81% |
| Dec 31, 2024 | -75.47% |
| Sep 30, 2024 | -70.88% |
| Jun 30, 2024 | 45.59% |
| Mar 31, 2024 | -2.27% |
| Dec 31, 2023 | 67.17% |
| Sep 30, 2023 | 33.34% |
| Jun 30, 2023 | -8.35% |
| Mar 31, 2023 | -17.94% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | -50.66% |
| Jun 30, 2022 | -6.13% |
| Mar 31, 2022 | -39.89% |
| Dec 31, 2021 | -31.50% |
| Sep 30, 2021 | -7.19% |
| Jun 30, 2021 | -211.73% |
| Mar 31, 2021 | -0.51% |
| Dec 31, 2020 | -7.47% |
| Sep 30, 2020 | -61.90% |
| Jun 30, 2020 | 39.85% |
| Mar 31, 2020 | -27.58% |
| Dec 31, 2019 | -13.10% |
| Sep 30, 2019 | -53.82% |
| Jun 30, 2019 | -37.05% |
| Mar 31, 2019 | -12,175,022.60% |
| Dec 31, 2018 | -281.03% |
| Sep 30, 2018 | -10,189,515.46% |
| Jun 30, 2018 | -4.29% |
| Mar 31, 2018 | -100.00% |
| Mar 31, 2017 | 6,170,813.71% |
| Mar 31, 2016 | 100.00% |
| Mar 31, 2015 | -4,065,727,522.11% |